<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36599625</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>21</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-2044</ISSN><JournalIssue CitedMedium="Internet"><Volume>108</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Archives of disease in childhood</Title><ISOAbbreviation>Arch Dis Child</ISOAbbreviation></Journal><ArticleTitle>Post-COVID-19 condition at 6 months and COVID-19 vaccination in non-hospitalised children and young people.</ArticleTitle><Pagination><StartPage>289</StartPage><EndPage>295</EndPage><MedlinePgn>289-295</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1136/archdischild-2022-324656</ELocationID><Abstract><AbstractText Label="OBJECTIVES">To describe the physical and mental health of children and young people (CYP) 6&#x2009;months after infection with SARS-CoV-2 and explore whether this varies by COVID-19 vaccination.</AbstractText><AbstractText Label="DESIGN">A non-hospitalised, national cohort of people aged 11-17&#x2009;years old with PCR-confirmed SARS-CoV-2 infection and PCR negatives matched at study invitation, by age, sex, region and date of testing who completed questionnaires 6&#x2009;months after PCR testing. The questionnaire included 21 symptoms and standardised scales (eg, EQ-5D-Y and Chalder Fatigue Scale).</AbstractText><AbstractText Label="RESULTS">6407 test-positive and 6542 test-negative CYP completed the 6-month questionnaire: 60.9% of test-positive vs 43.2% of test-negative CYP reported at least one symptom 6&#x2009;months post-test; 27.6% of test-positive vs 15.9% of test-negative CYP reported 3+ symptoms. Common symptoms at 6&#x2009;months were tiredness and shortness of breath among both test-positive and test-negative CYP; however, the prevalence of both was higher in test-positive (38.4% and 22.8%, respectively) compared with test-negative CYP (26.7% and 10.9%, respectively). 24.5% test-positive vs 17.8% test-negative CYP met the Delphi research definition of long COVID. Mental health, well-being, fatigue and health-related quality of life scores were similar among test-positive and test-negative CYP 6&#x2009;months post-test. Similarly, symptomatology was similar among COVID-19-vaccinated and COVID-19-unvaccinated test-positive and test-negative CYP.</AbstractText><AbstractText Label="CONCLUSIONS">Six-months post-PCR testing, CYP who tested positive for SARS-CoV-2 had similar symptoms to those who tested negative, but test-positive CYP had higher symptom prevalence. Mental health, well-being, fatigue and health-related quality of life were similar among test-positive and test-negative CYP, and symptoms at 6&#x2009;months were similar in COVID-19 vaccinated and unvaccinated.</AbstractText><AbstractText Label="TRIAL REGISTRATION NUMBER">ISRCTN 34804192.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pinto Pereira</LastName><ForeName>Snehal M</ForeName><Initials>SM</Initials><Identifier Source="ORCID">0000-0002-0876-8757</Identifier><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, London, UK snehal.pereira@ucl.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nugawela</LastName><ForeName>Manjula D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rojas</LastName><ForeName>Natalia K</ForeName><Initials>NK</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shafran</LastName><ForeName>Roz</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-2729-4961</Identifier><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McOwat</LastName><ForeName>Kelsey</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Immunisation Department, Public Health England, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simmons</LastName><ForeName>Ruth</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Immunisation Department, Public Health England, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ford</LastName><ForeName>Tamsin</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heyman</LastName><ForeName>Isobel</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0001-7358-9766</Identifier><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ladhani</LastName><ForeName>Shamez N</ForeName><Initials>SN</Initials><Identifier Source="ORCID">0000-0002-0856-2476</Identifier><AffiliationInfo><Affiliation>Immunisation Department, Public Health England, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Paediatric Infectious Diseases Research Group, St George's University, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheung</LastName><ForeName>Emily Y</ForeName><Initials>EY</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fox-Smith</LastName><ForeName>Lana</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dalrymple</LastName><ForeName>Emma</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stephenson</LastName><ForeName>Terence</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-8871-7847</Identifier><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ISRCTN</DataBankName><AccessionNumberList><AccessionNumber>ISRCTN34804192</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/P020372/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Arch Dis Child</MedlineTA><NlmUniqueID>0372434</NlmUniqueID><ISSNLinking>0003-9888</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">adolescent health</Keyword><Keyword MajorTopicYN="N">child health</Keyword><Keyword MajorTopicYN="N">paediatrics</Keyword></KeywordList><CoiStatement>Competing interests: TS is Chair of the Health Research Authority and therefore recused himself from the Research Ethics Application. Trudie Chalder is a member of the National Institute for Health and Care Excellence committee for long COVID. She has written self-help books on chronic fatigue and has done workshops on chronic fatigue and post-infectious syndromes.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>4</Day><Hour>21</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36599625</ArticleId><ArticleId IdType="pmc">PMC10086284</ArticleId><ArticleId IdType="doi">10.1136/archdischild-2022-324656</ArticleId><ArticleId IdType="pii">archdischild-2022-324656</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
World Health Organization . WHO/Europe | Child and adolescent health - COVID-19 and Children, 2022. Available: https://www.euro.who.int/en/health-topics/Life-stages/child-and-adolescent-health/covid-19-and-children [Accessed 06 Jun 2022].</Citation></Reference><Reference><Citation>Behnood SA, Shafran R, Bennett SD, et al. . Persistent symptoms following SARS-CoV-2 infection amongst children and young people: a meta-analysis of controlled and uncontrolled studies. J Infect 2022;84:158&#x2013;70. 10.1016/j.jinf.2021.11.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.11.011</ArticleId><ArticleId IdType="pmc">PMC8604800</ArticleId><ArticleId IdType="pubmed">34813820</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero Diego KL, Marie D, Jens D, et al. . Long COVID: pathophysiology &#x2013; epidemiology and patient needs. health services research (hsr. Brussels.: Belgian Health Care Knowledge Centre (KCE), 2021.</Citation></Reference><Reference><Citation>Say D, Crawford N, McNab S, et al. . Post-acute COVID-19 outcomes in children with mild and asymptomatic disease. Lancet Child Adolesc Health 2021;5:e22&#x2013;3. 10.1016/S2352-4642(21)00124-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(21)00124-3</ArticleId><ArticleId IdType="pmc">PMC8057863</ArticleId><ArticleId IdType="pubmed">33891880</ArticleId></ArticleIdList></Reference><Reference><Citation>Molteni E, Sudre CH, Canas LS, et al. . Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2. Lancet Child Adolesc Health 2021;5:708&#x2013;18. 10.1016/S2352-4642(21)00198-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(21)00198-X</ArticleId><ArticleId IdType="pmc">PMC8443448</ArticleId><ArticleId IdType="pubmed">34358472</ArticleId></ArticleIdList></Reference><Reference><Citation>Osmanov IM, Spiridonova E, Bobkova P, et al. . Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC global follow-up protocol: a prospective cohort study. Eur Respir J 2022;59:2101341. 10.1183/13993003.01341-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01341-2021</ArticleId><ArticleId IdType="pmc">PMC8576804</ArticleId><ArticleId IdType="pubmed">34210789</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnusson K, Skyrud KD, Suren P, et al. . Healthcare use in 700&#x2009;000 children and adolescents for six months after covid-19: before and after register based cohort study. BMJ 2022;376:e066809. 10.1136/bmj-2021-066809</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-066809</ArticleId><ArticleId IdType="pmc">PMC8762452</ArticleId><ArticleId IdType="pubmed">35039315</ArticleId></ArticleIdList></Reference><Reference><Citation>Borch L, Holm M, Knudsen M, et al. . Long COVID symptoms and duration in SARS-CoV-2 positive children - a nationwide cohort study. Eur J Pediatr 2022;181:1597&#x2013;607. 10.1007/s00431-021-04345-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-021-04345-z</ArticleId><ArticleId IdType="pmc">PMC8742700</ArticleId><ArticleId IdType="pubmed">35000003</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikkenborg Berg S, Dam Nielsen S, Nygaard U, et al. . Long COVID symptoms in SARS-CoV-2-positive adolescents and matched controls (LongCOVIDKidsDK): a national, cross-sectional study. Lancet Child Adolesc Health 2022;6:240&#x2013;8. 10.1016/S2352-4642(22)00004-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00004-9</ArticleId><ArticleId IdType="pmc">PMC8820960</ArticleId><ArticleId IdType="pubmed">35143771</ArticleId></ArticleIdList></Reference><Reference><Citation>
GOV.UK . Vaccinations in the UK | coronavirus in the UK, 2022. Available: https://coronavirus.data.gov.uk/details/vaccinations [Accessed 06 Jun 2022].</Citation></Reference><Reference><Citation>Antonelli M, Penfold RS, Merino J, et al. . Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID symptom study APP: a prospective, community-based, nested, case-control study. Lancet Infect Dis 2022;22:43&#x2013;55. 10.1016/S1473-3099(21)00460-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00460-6</ArticleId><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Bermingham C, Pouwels KB, et al. . Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study. BMJ 2022;377:e069676. 10.1136/bmj-2021-069676</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069676</ArticleId><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T, Shafran R, De Stavola B, et al. . Long COVID and the mental and physical health of children and young people: national matched cohort study protocol (the clock study). BMJ Open 2021;11:e052838. 10.1136/bmjopen-2021-052838</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-052838</ArticleId><ArticleId IdType="pmc">PMC8392739</ArticleId><ArticleId IdType="pubmed">34446502</ArticleId></ArticleIdList></Reference><Reference><Citation>
Sigfrid L, Buonsenso D, Galvin A, et al. . ISARIC global COVID-19 paediatric follow-up, 2021. Available: https://isaric.org/research/covid-19-clinical-research-resources/paediatric-follow-up/ [Accessed 02 Nov 2021].</Citation></Reference><Reference><Citation>Devlin N, Parkin D, Janssen B. Chapter 3 Analysis of EQ VAS Data. In: Devlin N, Parkin D, Janssen B, eds. Methods for Analysing and Reporting EQ-5D Data [Internet]. Cham: Springer, 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">33347096</ArticleId></ArticleIdList></Reference><Reference><Citation>Wille N, Badia X, Bonsel G, et al. . Development of the EQ-5D-Y: a child-friendly version of the EQ-5D. Qual Life Res 2010;19:875&#x2013;86. 10.1007/s11136-010-9648-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-010-9648-y</ArticleId><ArticleId IdType="pmc">PMC2892611</ArticleId><ArticleId IdType="pubmed">20405245</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodman R. Psychometric properties of the strengths and difficulties questionnaire. J Am Acad Child Adolesc Psychiatry 2001;40:1337&#x2013;45. 10.1097/00004583-200111000-00015</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00004583-200111000-00015</ArticleId><ArticleId IdType="pubmed">11699809</ArticleId></ArticleIdList></Reference><Reference><Citation>Tennant R, Hiller L, Fishwick R, et al. . The Warwick-Edinburgh mental well-being scale (WEMWBS): development and UK validation. Health Qual Life Outcomes 2007;5:63. 10.1186/1477-7525-5-63</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1477-7525-5-63</ArticleId><ArticleId IdType="pmc">PMC2222612</ArticleId><ArticleId IdType="pubmed">18042300</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalder T, Berelowitz G, Pawlikowska T, et al. . Development of a fatigue scale. J Psychosom Res 1993;37:147&#x2013;53. 10.1016/0022-3999(93)90081-P</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-3999(93)90081-P</ArticleId><ArticleId IdType="pubmed">8463991</ArticleId></ArticleIdList></Reference><Reference><Citation>
Office for National Statistics . Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK statistical bulletins, 2022. Available: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/previousReleases [Accessed 01 Jul 2022].</Citation></Reference><Reference><Citation>Stephenson T, Pinto Pereira SM, Shafran R, et al. . Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (clock): a national matched cohort study. Lancet Child Adolesc Health 2022;6:230&#x2013;9. 10.1016/S2352-4642(22)00022-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00022-0</ArticleId><ArticleId IdType="pmc">PMC8820961</ArticleId><ArticleId IdType="pubmed">35143770</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T, Allin B, Nugawela MD, et al. . Long COVID (post-COVID-19 condition) in children: a modified Delphi process. Arch Dis Child 2022;107:674&#x2013;80. 10.1136/archdischild-2021-323624</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2021-323624</ArticleId><ArticleId IdType="pmc">PMC8983414</ArticleId><ArticleId IdType="pubmed">35365499</ArticleId></ArticleIdList></Reference><Reference><Citation>Nugawela MD, Stephenson T, Shafran R, et al. . Developing a model for predicting impairing physical symptoms in children 3 months after a SARS-CoV-2 PCR-test: the clock study. medRxiv 2022. 10.1101/2022.04.01.22273117</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.04.01.22273117</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandenbroucke JP, von Elm E, Altman DG, et al. . Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. Ann Intern Med 2007;147:W&#x2013;94. 10.7326/0003-4819-147-8-200710160-00010-w1</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-147-8-200710160-00010-w1</ArticleId><ArticleId IdType="pubmed">17938389</ArticleId></ArticleIdList></Reference><Reference><Citation>Rytter MJH. Difficult questions about long COVID in children. Lancet Child Adolesc Health 2022;6:595&#x2013;7. 10.1016/S2352-4642(22)00167-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00167-5</ArticleId><ArticleId IdType="pmc">PMC9221929</ArticleId><ArticleId IdType="pubmed">35752193</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>